Pseudo-acetylation of K326 and K328 of actin disrupts Drosophila melanogaster indirect flight muscle structure and performance by Meera C. Viswanathan et al.
ORIGINAL RESEARCH
published: 28 April 2015
doi: 10.3389/fphys.2015.00116
Frontiers in Physiology | www.frontiersin.org 1 April 2015 | Volume 6 | Article 116
Edited by:
Julien Ochala,





University of New Mexico, USA
*Correspondence:
Anthony Cammarato,
Division of Cardiology, Department of
Medicine, Johns Hopkins University
School of Medicine, 720 Rutland




This article was submitted to
Striated Muscle Physiology,
a section of the journal
Frontiers in Physiology
Received: 07 November 2014
Accepted: 26 March 2015
Published: 28 April 2015
Citation:
Viswanathan MC, Blice-Baum AC,
Schmidt W, Foster DB and
Cammarato A (2015)
Pseudo-acetylation of K326 and K328
of actin disrupts Drosophila
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Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
In striated muscle tropomyosin (Tm) extends along the length of F-actin-containing thin
filaments. Its location governs access of myosin binding sites on actin and, hence,
force production. Intermolecular electrostatic associations are believed to mediate
critical interactions between the proteins. For example, actin residues K326, K328,
and R147 were predicted to establish contacts with E181 of Tm. Moreover, K328 also
potentially forms direct interactions with E286 of myosin when the motor is strongly
bound. Recently, LC-MS/MS analysis of the cardiac acetyl-lysine proteome revealed
K326 and K328 of actin were acetylated, a post-translational modification (PTM) that
masks the residues’ inherent positive charges. Here, we tested the hypothesis that
by removing the vital actin charges at residues 326 and 328, the PTM would perturb
Tm positioning and/or strong myosin binding as manifested by altered skeletal muscle
function and structure in the Drosophila melanogaster model system. Transgenic flies
were created that permit tissue-specific expression of K326Q, K328Q, or K326Q/K328Q
acetyl-mimetic actin and of wild-type actin via the UAS-GAL4 bipartite expression
system. Compared to wild-type actin, muscle-restricted expression of mutant actin had
a dose-dependent effect on flight ability. Moreover, excessive K328Q and K326Q/K328Q
actin overexpression induced indirect flight muscle degeneration, a phenotype consistent
with hypercontraction observed in other Drosophila myofibrillar mutants. Based on
F-actin-Tm and F-actin-Tm-myosin models and on our physiological data, we conclude
that acetylating K326 and K328 of actin alters electrostatic associations with Tm and/or
myosin and thereby augments contractile properties. Our findings highlight the utility of
Drosophila as amodel that permits efficient targeted design and assessment of molecular
and tissue-specific responses to muscle protein modifications, in vivo.
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Introduction
Striated muscle contraction results from transient interactions between myosin-containing thick
filaments and actin-containing thin filaments. Contractile regulation is achieved by Ca2+-
dependent modulation of myosin S1 cross-bridge binding to actin by the thin filament-associated
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troponin-tropomyosin complex (reviewed in Tobacman, 1996;
Gordon et al., 2000; Brown and Cohen, 2005; Lehman and
Craig, 2008). The location of continuous troponin-tropomyosin
complexes along the surface of F-actin governs the access of
myosin binding sites and, hence, force production (Haselgrove,
1973; Huxley, 1973; Parry and Squire, 1973; McKillop and
Geeves, 1993; Lehman et al., 1994; Vibert et al., 1997). Under
conditions of low Ca2+, the troponin complex constrains
tropomyosin (Tm) in a position that occludes myosin target
sites on actin. Consequently, Tm sterically blocks and limits
myosin binding, and relaxation results. Duringmuscle activation,
Ca2+ binds to troponin and triggers movement of Tm away
from myosin binding sites. This relocation partially relieves the
structural blocking imposed by Tm. Initial myosin binding on
thin filaments further displaces Tm and exposes myosin binding
sites along F-actin, thereby contributing to the cooperative
activation of contraction.
Although the specific residues that constitute the binding
interface of actin and Tm are not completely known, it is
well accepted that the association of Tm with actin is largely
electrostatic (Lorenz et al., 1995; Brown and Cohen, 2005;
Barua et al., 2011, 2013; Li et al., 2011). Recently, models
of the conserved binding interface between actin and Tm
in various states have been proposed based on molecular
evolutionary and mutational analysis, computational chemistry,
and electron microscopy reconstructions (Barua et al., 2011,
2013; Li et al., 2011; Behrmann et al., 2012; Von Der Ecken et al.,
2015). Structural studies of F-actin-Tm and F-actin-Tm-myosin
revealed that several amino acids on actin can potentially form
FIGURE 1 | Critical electrostatic F-actin-Tm and F-actin-Tm-myosin
interactions. (A) Molecular models showing the location of tropomyosin
(Tm) (blue) on actin (yellow and green) in the absence and presence of the
myosin head (S1) (red) bound in rigor. The F-actin-Tm and rigor
F-actin-Tm-myosin structures are based on those generated by Li et al.
(2011) and Behrmann et al. (2012) respectively. (B) Enlarged views illustrate
critical electrostatic associations between actin and Tm in the absence or
presence of S1. K328 on actin (circled) interacts with E181 of Tm in the
absence of myosin (left) and with E286 of myosin when S1 is bound in rigor
(right). Note the azimuthal movement of Tm across F-actin. (C) Projected and
enlarged views highlight vital electrostatic interactions of actin residues R147,
K326, and K328 with E181 of Tm, in the absence of myosin, and of K328 of
actin and E286 of S1 when myosin is bound in rigor. These associations are
likely critical for thin filament and muscle function.
distinct contacts with Tm in the absence and presence of myosin
S1 (Li et al., 2011; Behrmann et al., 2012; Von Der Ecken et al.,
2015). For example, in the absence of S1, a cluster of basic actin
residues comprised of K326, K328, and R147 appeared poised to
clasp onto E181 of Tm to establish highly favorable associations
(Figure 1) (Li et al., 2011). Interestingly, K328 also interacts
electrostatically with E286 of S1 to help define a strong contact
point between actin and rigor-bound myosin (Behrmann et al.,
2012).
Alterations to thin filament proteins affect the properties of
muscle. Missense mutations, for instance, can disrupt conserved
interfaces among cardiac thin filament subunits and initiate
diverse cardiomyopathies (Tardiff, 2011). Similar to disease-
causing mutations, post translational modifications (PTMs)
also alter the chemical nature of thin filament subunits.
Although less-well appreciated, these modifications are widely
employed in vivo, occur through enzymatic and non-enzymatic
mechanisms, and direct both physiological and pathological
processes (Terman and Kashina, 2013). PTMs add or remove a
functional group to or from specific amino acid residues, which
can induce changes in protein structure, activity, or binding
partners (van Eyk, 2011). To date, more than 400 different PTMs
have been described, although far fewer have been documented
in higher organisms (Agnetti et al., 2011). In the cardiac
subproteome, phosphorylation is by far the best-described PTM
(Sumandea et al., 2004; Agnetti et al., 2011; Solaro and Kobayashi,
2011; van Eyk, 2011). It has been observed for 80% of the
myofilamentous proteins (Agnetti et al., 2011). However, the
effects of the majority of the potential PTMs have not been fully
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FIGURE 2 | Multiple sequence alignment of actin isoforms. Multiple
sequence alignment of skeletal and cardiac actin from Homo sapiens (Hs),
Cavia porcellus (Cp), and Drosophila melanogaster (Dm) reveals highly
conserved proteins. ACTA, skeletal muscle actin; ACTC, cardiac muscle actin;
Act88F, Drosophila indirect flight muscle actin; Act57B, Drosophila cardiac
actin. Residues are shaded based on degree of conservation. An (*) indicates
positions that have identical residues, a (:) indicates substitution with high
structural similarity, and a (.) indicates substitution low structural similarity.
investigated, in part because of a lack of technologies needed
to target and reliably identify them. Moreover, compared to
inherited mutations, the influence of relatively few PTMs on
contractile performance have been examined in the physiological
context of muscle.
Actin is an abundant and highly conserved protein (Figure 2).
It participates in more protein-protein interactions than any
known protein and is subject to a number of PTMs (Herman,
1993; Dominguez and Holmes, 2011; Terman and Kashina,
2013). Characterizing these modifications constitutes a rapidly
expanding area within actin studies and muscle biology
(Terman and Kashina, 2013). Phosphorylation, methylation,
ADP-ribosylation, oxidation, arginylation, O-GlcNAcylation,
ubiquitylation, and acetylation are examples of major actin
modifications, many of which have now been confirmed in
sarcomeric actin. For example, K326 and K328 of actin isolated
from various cell lines were shown to be acetylated (Choudhary
et al., 2009) and, as recently described by Foster et al. (2013) these
residues were also shown to be acetylated on actin recovered from
the myofilament fraction of guinea pig hearts. Acetylation is a
reversible PTM that neutralizes the positive charge of K326 and
K328 on actin. Unlike the N-terminal acetylation, acetylation of
these residues has unknown function. Based on in vitro and in
silico structural predictions, removal of positively charged amino
acids that are potentially critical to Tm and myosin electrostatic
associations likely alters muscle performance substantially and in
diverse ways.
Here, we aimed to investigate the in vivo physiological
and morphological consequences of acetylating actin residues
K326 and K328 on muscle. We chose the indirect flight
muscle (IFM) of D. melanogaster as our primary experimental
vehicle. Drosophila IFMs are highly amenable to mechanical and
structural analyses, are not required for viability, exhibit a stretch
activation response that is similar to that of cardiac muscle, and
provide ample material that is easily isolated for biochemical and
biophysical experimentation (Bing et al., 1998; Razzaq et al., 1999;
Cammarato et al., 2004; Vikhorev et al., 2010; Swank, 2012). The
vast array of genetic tools available to manipulate the fly’s genome
also provides unique opportunities to examine how thin filament
modifications affect muscle structure and performance. The
GAL4-UAS system simplifies tissue-specific expression of mutant
transgenes (Brand and Perrimon, 1993). However, previous
studies suggested that IFM myofibril assembly and flight ability
are highly sensitive to the stoichiometry of muscle proteins
(Beall and Fyrberg, 1991; Bernstein et al., 1993), and therefore,
the utility of this bipartite expression system for investigating
major contractile components has been questioned. For example,
despite normal sarcomere appearance, overexpression of several
UAS-GFP-actin alleles was shown to exclusively affect IFM
function, leading to flightless adults that were otherwise healthy
(Röper et al., 2005). The effects of non-GFP fusion constructs on
IFM performance were not tested. Therefore, to determine if the
IFM can serve as a viable, conditional model system for probing
the effects of PTMs on myofibrillar components, we tested
the hypotheses that (1) GAL4-UAS-mediated overexpression
of a Drosophila cardiac actin isoform in the IFM would not
perturb gross morphology or flight performance as determined
by standard metrics and that (2) expression of K326Q, K328Q,
or K326Q/K328Q acetyl-mimetic cardiac actin disrupts vital
electrostatic interactions required for Tm positioning and/or
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strong myosin binding, in vivo, as manifested by perturbed IFM
structure and function. Using four muscle-specific GAL4 drivers
we found that expressing wild-type Drosophila cardiac actin had
no effect on flight or gross muscle organization. Relatively high
expression levels of K326Q cardiac actin mildly affected flight
ability, whereas excessive amounts of K328Q and K326Q/K328Q
cardiac actin eliminated flight and triggered IFM destruction.
Based on F-actin-Tm and F-actin-Tm-myosin models and on
our physiological data, we propose that acetylating K326 and
K328 of actin alters crucial electrostatic associations with Tm
and/or myosin and thereby promotes actomyosin associations
and modulates muscle performance. Our findings highlight the
utility of Drosophila as a model that permits efficient targeted
design and assessment of tissue-specific responses to muscle
protein modifications, in vivo.
Materials and Methods
Structural Modeling
Models of the F-actin-Tm (Li et al., 2011; Orzechowski et al.,
2014) and the rigor F-actin-Tm-myosin (PDB ID: 4A7F)
(Behrmann et al., 2012) binding interfaces were generated using
the molecular modeling program, Chimera version 1.9 (Pettersen
et al., 2004).
Multiple Sequence Alignment
Sequence comparison of skeletal and cardiac actin isoforms
from Homo sapiens, Cavia porcellus, and D. melanogaster
was performed using the Clustal Omega multiple sequence
alignment program. Residues were shaded based on degree of
conservation.
Fly Stocks
All flies were raised at 25◦C on a standard cornmeal-yeast-
sucrose-agar medium. The w1118 strain was obtained from
Genetic Services Inc. (Sudbury, MA) and the Mef2-GAL4 driver
line (y1 w∗; P{GAL4-Mef2.R}3) from the BloomingtonDrosophila
Stock Center (Bloomington, IN). The MHC-GAL4 (MHC-
GAL482) line described by Marek et al. (2000) was obtained from
Dr. Rolf Bodmer (Sanford Burnham Medical Research Institute,
La, Jolla, CA). The UH3-GAL4 (Singh et al., 2014) and the
Act88F-GAL4 (88F2) (Bryantsev et al., 2012) lines were gifts from
Dr. Upendra Nongthomba (Indian Institute of Science, Banglore,
India) and Dr. Richard M. Cripps (University of New Mexico,
Albuquerque, NM) respectively. The Mhc10 (w; Mhc10/Mhc10;
TM2/MKRS) IFM-specific myosin null line was acquired from
Dr. Sanford I. Bernstein (San Diego State University, San
Diego, CA). Mef2-GAL4> UAS-Act57BWT ; Mhc10/+ and UAS-
Act57BK328Q; Mhc10/+ Drosophila were generated by standard
mating procedures.
Construction of UAS-Actin Transgenes
The N-terminally-labeled GFP-actin construct
(pUASp.Act57BGFP.WT) was generously provided by Dr. Katja
Röper (MRC- Laboratory of Molecular Biology, Cambridge,
UK). The Act57BGFP.WT and Act57BWT cDNA sequences were
subsequently inserted into the pUASTattB vector (obtained
from Dr. Christopher Potter, Johns Hopkins University) using
the KpnI and XbaI and the NotI and XbaI restriction sites
respectively. The pUASTattB vector includes the Drosophila
miniwhite (w+) gene as a selectable eye color marker. The
Act57B actin acetyl-mimetic mutations, K326Q, K328Q, and
K326Q/K328Q, were generated by site-directed mutagenesis
using specific primer pairs and the QuikChange Site-directed
mutagenesis kit (Agilent Technologies).
List of primers for site-directed mutagenesis:
Act57BK326Q (+) primer 5′ CCATCCACCATCCAGA
TCAAGATCATT 3′
Act57BK326Q (−) primer 5′ AATGATCTTGATCTGG
ATGGTGGATGG 3′
Act57BK328Q (+) primer 5′ ACCATCAAGATCCAGA
TCATTGCTCCC 3′
Act57BK328Q (−) primer 5′ GGGAGCAATGATCTGG
ATCTTGATGGT 3′
Act57BK326Q/K328Q (+) primer 5′ TCCACCATCCAGATCC
AGATCATTGCT 3′
Act57BK326Q/K328Q (−) primer 5′ AGCAATGATCTGGAT
CTGGATGGTGGA 3′
Generation of Transgenic Drosophila
The pUASTattB constructs were injected into attp40 Drosophila
embryos for PhiC31 integrase mediated site-specific transgenesis
(transgene landing site cytolocation 25C7) by Genetic Services,
Inc. Injected adults were crossed to w1118 flies and the progeny
screened for pigmented eye color, which reflects the presence
of the miniwhite (w+) marker and the transgene, an indicator
of successful transformation. Each transformant fly was then
crossed into the w1118 background to generate stable transgenic
lines.
Verification of Transgene Expression
Transgenic actin expression was verified by isolating total RNA
from bisected thoraces or dissected IFMs of 10 Mef2-GAL4>
UAS-Act57BWT , UAS-Act57BK326Q, UAS-Act57BK328Q, or UAS-
Act57BK326Q/K328Q flies using the Quick-RNA microprep kit
(Zymo Research Corp). Contaminating DNA was removed
with RNase free DNase I (Zymo Research Corp). One
step RT-PCR was carried out with the Qiagen QuantiTect
Reverse Transcription Kit (Qiagen Inc) and 10 ng RNA
per reaction. The cDNA was amplified using an Act57B
primer pair (5′ CCCTGTACGCCTCCGGTCGTA 3′ and 5′
TTAGAAGCACTTGCGGTGGAC 3′) and the amplified product
was sequenced at the Johns Hopkins Synthesis and Sequencing
facility.
Transgenic muscle-restricted protein expression was
confirmed using the UAS-Act57BGFP.WT reporter line in
conjunction with either the MHC-GAL4 or Mef2-GAL4 drivers.
Two-day-old adult progeny were imaged using a Leica M165FC
fluorescent stereo microscope and a Leica EC3 digital camera.
Protein Quantification
Virgin MHC-, Mef2-, UH3-, and Act88F-GAL4 female flies
were crossed with male flies harboring the UAS-Act57BGFP.WT
transgene. To quantitate the amount of Act57BGFP.WT transgenic
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actin driven by each muscle-specific driver, two whole thoraces
of, or IFMs from three resulting progeny were dissected and
homogenized in Laemmli Sample Buffer (Bio-Rad Laboratories).
Each biological sample was then incubated briefly at 100◦C
and increasing amounts of protein from each sample were
loaded on a 4–15% SDS-PAGE gel (Bio-Rad Laboratories),
electrophoresed, and blotted onto a nitrocellulose membrane
using the Trans-Blot R© TurboTM Transfer system (Bio-Rad
Laboratories). Membranes were blocked with gentle shaking in
PBS odyssey blocking buffer (LI-COR Biosciences) for one hour,
and incubated with primary rabbit anti-actin (Proteintech), goat
anti-GFP (R&D), and goat anti-GAPDH (Genscript) antibodies
overnight at 4◦C. The membranes were rinsed three–four
times, 10–15min each in 1x TBST (1X TBS with 0.1% tween-
20) and then probed with Donkey anti-rabbit and Donkey
anti-goat IRDye secondary antibodies (LI-COR Biosciences)
for 60–90min at room temperature. The membranes were
rinsed again two–three times, 10–15min each with 1X TBST
followed by a final rinse in 1X TBS. The membranes were
subsequently scanned using an Odyssey Infrared Imager (LI-
COR Biosciences) (λ = 700 and 800 nm) and analyzed using
Odyssey Application Software (v3.030, LI-COR Biosciences).
Thoracic and IFM protein quantification was performed on
five or eight independent biological samples respectively, with
six or four technical replicates each. Mean values (± SEM)
of actin and GFP intensities normalized to respective GAPDH
intensities were determined. Significance was assessed via One-
Way ANOVA with a Bonferroni’s multiple comparison test for
thoracic, and via the Mann-Whitney test for IFM samples using
GraphPad Prism5.
Flight Testing
Flight tests were performed as described by Drummond et al.
(1991). Newly eclosed male and female flies were aged for two
days at 25◦C. Each fly was released into the center of a plexiglass
chamber with a light source positioned at the top at 23◦C and
assigned a flight index of six for upward flight, four for horizontal,
two for downward, or zero for no flight. The average flight index
from 100–300 flies was calculated for each genotype. Flight assays
for Act88F-GAL4-expressing flies were conducted exclusively on
females as males consistently displayed severe flight impairment.
Values represent mean ± SEM. Significance was assessed using a
Kruskal-Wallis One-Way ANOVA.
Climbing Assay
Climbing tests were conducted on two-day-old flies at room
temperature. Small groups of ∼20 flies were placed in covered,
cylindrical vials (2.5 cm diameter × 20 cm high), which were
aligned with one centimeter markings to measure the height each
fly climbed in five seconds. The test was repeated 10 times for
each set of flies. The average climbing distance for each fly was
recorded for 30–160 flies per genotype. Values represent mean±
SEM. Significance was assessed using a Kruskal-Wallis One-Way
ANOVA.
Imaging of Indirect Flight Muscles
Polarized light microscopy of hemi-thoraces to examine the
gross morphology of two-day-oldMef2-GAL4> UAS-Act57BWT ,
UAS-Act57BK326Q, UAS-Act57BK328Q, or UAS-Act57BK326Q/K328Q
adult Drosophila IFM was performed as described previously
(Nongthomba and Ramachandra, 1999). Briefly, flies were
anesthetized, and heads and abdomens removed. Thoraces
were fixed overnight in 4% formaldehyde at 4◦C and rinsed
in PBS the following day. The specimens were laid supine
on a glass slide and snap frozen in liquid nitrogen for 10 s.
Frozen thoraces were immediately bisected down the midsagittal
plane using a razor blade and IFMs were visualized using
a Leica DM5000B microscope at 10X magnification with
polarizing filters. Images were taken with a Hamamatsu digital
camera.
Fluorescent microscopy was employed to improve
pathohistological characterization of IFMs from young
(< four hour old) and two-day-old adult Act88F-GAL4>
UAS-Act57BWT , UAS-Act57BK326Q, UAS-Act57BK328Q, and
UAS-Act57BK326Q/K328Q Drosophila. Thoraces were prepared
and bisected as described above, followed by staining with
1:100 Alexa-594 Phalloidin in PBST overnight at 4◦C. Samples
were rinsed with PBS before imaging with the EVOS R© FL Cell
Imaging System (Life Technologies) at 4X magnification.
Results
Actin Sequence Analysis
The genomes of human, guinea pig, and fly contain six highly
conserved actin genes. As found in vertebrates, D. melanogaster
expresses specific isoforms of actin in adult skeletal and cardiac
muscle. The Actin88F (Act88F) gene encodes all sarcomeric actin
of Drosophila IFM (Fyrberg et al., 1983; Hiromi and Hotta,
1985; Nongthomba et al., 2001) while Actin57B (Act57B) is one
of two genes encoding sarcomeric actin in the adult fly heart
(Cammarato et al., 2011; Shah et al., 2011). The skeletal and
cardiac actin isoforms differ in only a few amino acids within and
between species (Figure 2).
Generation of Transgenic Drosophila and
Confirmation of Muscle-Restricted Transgene
Expression
To determine the consequences of masking the inherent charge
of actin residues K326 and K328 in vivo, we generated multiple
transgenic acetyl-mimetic lines that permitted muscle targeted
gene expression. Use of the PhiC31 integrase system ensured
all UAS-Act57B transgenes were integrated at an identical,
predetermined genomic location (Groth et al., 2004). Thus,
our results were directly comparable and any phenotypic
differences in control vs. mutant flies could be directly attributed
to neutralized lysine charges on the ectopically expressed
actin.
To confirm transcription of transgenic actin, flies with
constructs consisting of an upstream activating sequence (UAS)
followed by a downstreamAct57BWT ,Act57BK326Q,Act57BK328Q,
or Act57BK326Q/K328Q transgene were crossed with flies carrying
the GAL4 transactivation gene under the control of the Mef2-
promoter (Ranganayakulu et al., 1996). The progeny inherit
both genes and express the UAS-Act57B transgenes exclusively
in musculature. Total RNA was isolated from the thoraces of
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young (< two days old) flies of each genotype. First-strand
cDNA was synthesized followed by Act57B cDNA amplification.
The amplified cDNA contained nucleotide sequences unique
to the Act57B alleles, confirming transcription of the WT,
K326Q, K328Q, or the K326Q/K328Q Act57B cardiac actin
transgene (Figure 3). To rule out the possibility of contaminating
endogenous Act57B cDNA originating from non-IFM thoracic
musculature, amplified cDNA from the dissected IFMs of Mef2-
GAL4> UAS-Act57BWT flies was also sequenced, which verified
the presence and transcription of Act57BWT in Act88F-exclusive
musculature (not shown).
To visualize muscle-restricted expression of UAS-Act57B
transgenes, in vivo, flies carrying the UAS-Act57BGFP.WT
construct were crossed with flies harboring either the MHC-
or Mef2-GAL4 muscle-specific drivers. MHC-GAL4-driven
transgenic Act57BGFP.WT was readily observed in the thoracic
musculature, which is predominantly comprised of 13 pairs
of relatively large IFM fibers (Figure 4). Mef2-GAL4-driven
Act57BGFP.WT, however, was detected far more extensively, in
most somatic musculature.
Relative to MHC-GAL4, Mef2-GAL4 Drives
Elevated Expression Levels of Transgenic Actin
The PhiC31 integrase system for transgenic fly production limits
transgene expression variability and, when used in conjunction
with the GAL4-UAS system, permits the onset and magnitude
of expression to be manipulated via distinct drivers (Brand
and Perrimon, 1993; Groth et al., 2004; Goentoro et al.,
2006). To quantify differences in transgenic protein abundance,
dissected thoraces from flies expressing Act57BGFP.WT actin by
either MHC- or Mef2-GAL4 drivers, as well as from control
“non-driven” flies, were subjected to SDS-PAGE, transferred to
nitrocellulose, and probed for actin and for GFP (Figure 5A).
The resulting signal intensities from GFP and actin were
measured and normalized to that from GAPDH (Figures 5B,C).
As expected very little GFP was distinguished among the various
controls. Thoracic muscles from MHC- and Mef2-GAL4> UAS-
Act57BGFP.WT flies, however, exhibited detectable amounts of
GFP-actin. Mef2-GAL4 induced significantly higher expression
levels of the GFP-tagged actin in the thoracic musculature
compared to MHC-GAL4. The resulting normalized signal
was greater than two-fold higher than that determined for
MHC-GAL4> UAS-Act57BGFP.WT flies (1.66 ± 0.41 vs. 0.69 ±
0.07). These findings were corroborated using dissected IFMs,
which displayed a normalized Act57BGFP.WT signal that was
roughly three-fold higher for Mef2-GAL4> UAS-Act57BGFP.WT
compared to MHC-GAL4> UAS-Act57BGFP.WT fibers (6.04 ±
1.85 vs. 1.73± 0.37). The thoracic or IFM actin/GAPDH ratio did
not differ significantly among the genotypes tested (Figure 5C).
Estimation of signal intensities from the protein bands, detected
exclusively with the anti-actin antibody, suggested that Mef2-
GAL4> Act57BGFP.WT comprises ∼10–20% of total thoracic
actin (not shown).
GFP-labeled and Acetyl-Mimetic Cardiac Actin
Depress Drosophila Flight Ability and Climbing
Performance
Flight tests were performed on two-day-old MHC- and Mef2-
GAL4> UAS-Act57BGFP.WT , UAS-Act57BWT , UAS-Act57BK326Q,
UAS-Act57BK328Q, or UAS-Act57BK326Q/K328Q transgenic
Drosophila lines to determine if expression of wildtype or acetyl-
mimetic cardiac actin can support IFM function. The driver
lines, and the progeny of each driver line crossed to w1118 flies,
served as additional controls.MHC- andMef2-GAL4 Drosophila
by themselves, and the offspring of the driver lines crossed to
w1118, showed normal flight indices (FI = 5.69–5.83) in accord
with published values calculated for wildtype flies (Figure 6A)
(Drummond et al., 1991; Swank et al., 2003; Suggs et al., 2007;
FIGURE 3 | Confirmation of transgenic actin transcription.
Sequence chromatograms of an amplified stretch of Act57B cDNA
revealed transcription of the UAS-Act57B transgenes in the thoracic
musculature of Mef2-GAL4> UAS-Act57B transgenic flies. The
chromatograms also confirmed the presence and expression of K326Q,
K328Q, or K326Q/K328Q actin mutations (identified by the AAG →
CAG nucleotide transversion) in the sequenced Act57B cDNA
fragments.
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FIGURE 4 | Confirmation of muscle-restricted gene expression. Virgin
female flies expressing either the muscle-specific MHC-GAL4 or the
Mef2-GAL4 driver were mated with male flies carrying the
UAS-Act57BGFP.WT construct. Background fluorescence coming from the
musculature of the parental lines was minimal. However, fluorescence
emitted from the musculature of progeny, which inherit both a GAL4 driver
and the UAS-construct, was readily observed in both genotypes, confirming
tissue-specific expression of transgenic Act57B actin.
Cammarato et al., 2008; Wang et al., 2012). “Low dose” ectopic
expression of all UAS-Act57B actin constructs by MHC-GAL4
had no effect on flight ability. All lines performed equally well
(FI = 5.46–5.78). Thus, MHC-GAL4-driven GFP-tagged,
wildtype, or acetyl-mimetic Act57B actin supported flight.
Similar to previous results (Röper et al., 2005), Mef2-GAL4>
Act57BGFP.WT expression eliminated flight ability (FI = 0.03 ±
0.01) (Figure 6A). Interestingly, relatively “high dose” expression
of Act57B cardiac actin that lacked the GFP fusion tag had
no observable effect on flight as Mef2-GAL4> UAS-Act57BWT
Drosophila demonstrated wildtype-like flight ability (FI = 5.62
± 0.04). Unlike what was found in combination with MHC-
GAL4, expression of UAS-Act57BK326Q by Mef2-GAL4 had a
slight, but significant effect on the average flight value (FI = 4.99
± 0.09) whereas UAS-Act57BK328Q and UAS -Act57BK326Q/K328Q
expression abolished IFM function (FI = 0.11 ± 0.02 and
0.08 ± 0.04, respectively). Notably, Mef2-GAL4-driven UAS-
Act57BK326Q/K328Q actin expression predominantly resulted in
pupal lethality with relatively few adult flies emerging from their
puparia. Thus,Mef2-GAL4-drivenGFP-tagged or acetyl-mimetic
Act57B actin impaired flight and muscle performance.
To assess if expression of acetyl-mimetic cardiac actin
affected additional somatic musculature, the climbing ability
of w1118, Mef2-GAL4> UAS-Act57BWT , UAS-Act57BK326Q, UAS-
Act57BK328Q, and UAS-Act57BK326Q/K328Q flies was examined
(Figure 6B). Expression of UAS-Act57BWT actin had no
significant effect on climbing distance (8.33 ± 0.54 cm) relative
to w1118 controls (8.85 ± 0.49 cm). All acetyl-mimetic actin-
expressing flies, however, exhibited climbing defects compared
to w1118 and to Mef2-GAL4> UAS-Act57BWT Drosophila.
Flies expressing UAS-Act57BK326Q had a small but significant
reduction in climbing ability (6.14 ± 0.50 cm), while flies
expressing UAS-Act57BK328Q or UAS-Act57BK326Q/K328Q had
strikingly reduced climbing capabilities (4.22± 0.30 cm and 0.93
± 0.24 cm respectively) compared to controls. Furthermore, flies
expressing UAS-Act57BK326Q/K328Q actin performed significantly
worse than those expressing UAS-Act57BK328Q actin.
Mef2-GAL4> UAS-Act57BK328Q and
UAS-Act57BK326Q/K328Q Lack of Flight is
Associated with Loss of IFM Fibers
In addition to inducing a lack of flight, Mef2-GAL4>
Act57BK328Q and Act57BK326Q/K328Q acetyl-mimetic cardiac
actin expression also resulted in a “wings up” phenotype. This
phenotype is commonly associated with “hypercontracted”
and damaged IFM that occurs due to mutations in Drosophila
muscle proteins (Fyrberg et al., 1990; Beall and Fyrberg, 1991;
Kronert et al., 1995; An and Mogami, 1996; Reedy et al.,
2000; Nongthomba et al., 2003). Polarized light microscopy
was employed to investigate disturbances in gross IFM
morphology (Figure 6C). Mef2-GAL4> UAS-Act57BWT and
UAS-Act57BK326Q Drosophila displayed similar IFM fiber
structure. Both perpendicularly-oriented sets of fibers were
continuous and straight, spanning the entire thorax in each
line. However, Mef2-GAL4> UAS-Act57BK328Q and UAS-
Act57BK326Q/K328Q Drosophila were characterized by the absence
of continuous IFM fibers. Only occasionally was light observed
emerging from birefringent material closely associated with the
thoracic cuticle, which we assumed were IFM fiber remnants.
Interestingly, Mef2-GAL4> UAS-Act57BK328Q; Mhc10/+
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FIGURE 5 | Mef2-GAL4 drives higher expression levels of transgenic
actin relative to MHC-GAL4. Quantitative western blot analysis of
steady-state Act57BGFP.WT and total actin was performed on thoraces and
IFMs of Mef2-GAL4> UAS-Act57BGFP.WT and MHC-GAL4>
UAS-Act57BGFP.WT flies and of control flies two days after eclosion. (A)
Representative western blots showing elevated thoracic (left) and IFM (right)
levels of Act57BGFP.WT (probed with an anti-GFP primary antibody) when
driven by Mef2-GAL4 compared to MHC-GAL4. Actin and GAPDH (probed
with anti-actin and anti-GAPDH antibodies) abundance appeared relatively
consistent among genotypes. The GFP (B) and actin (C) intensities were
measured, normalized to that of GAPDH for five thoracic samples with six
technical replicates each and for eight IFM samples with four technical
replicates each, and averaged for each genotype. Mef2-GAL4 drove
significantly higher amounts of transgenic actin relative to MHC-GAL4
(∗P < 0.05).
Drosophila displayed a greater abundance of thoracic material
and birefringent musculature consistent with previous studies
that demonstrated a reduced number of myosin motors can
suppress mutant fiber destruction (Beall and Fyrberg, 1991;
Nongthomba et al., 2003). However, the extent of suppression
was incomplete as IFMs were still largely absent.
Relative to UH3-GAL4, Act88F-GAL4 Drives
Elevated Expression Levels of IFM-Restricted
Transgenic Actin
IFM-specific GAL4 drivers provide an additional resource to
further characterize the effects of pseudo-acetylated cardiac
actin on flight muscle function and morphology. To quantify
differences in transgenic protein abundance exclusively in IFMs,
dissected fibers from flies expressing Act57BGFP.WT driven by
either UH3- or Act88F-GAL4, as well as fibers from control “non-
driven” flies, were subjected to quantitative western blot analysis
(Figure 7A). The signal intensities from the GFP and actin bands
were measured and normalized to that from GAPDH. As found
in whole thoraces, GFP signals in IFMs from all control lines
were negligible (not shown), while IFMs from UH3- and Act88F-
GAL4> UAS-Act57BGFP.WT flies showed detectable amounts of
GFP-actin. Act88F-GAL4 induced significantly higher expression
levels of GFP-actin in the IFMs compared to UH3-GAL4
(10.31 ± 2.94 vs. 1.57 ± 0.52). No differences in the relative
abundance of non GFP-labeled, endogenous IFM actin were
identified (not shown).
IFM-Specific Expression of GFP-labeled or
Acetyl-Mimetic Actin Decreases Flight Ability in a
Dose-Dependent Manner
Flight tests were performed on two-day-old UH3- and Act88F-
GAL4 driver lines and on the progeny of each driver line
crossed to w1118 control, UAS-Act57BGFP.WT , UAS-Act57BWT ,
UAS-Act57BK326Q, UAS-Act57BK328Q, or UAS-Act57BK326Q/K328Q
transgenic Drosophila (Figure 7B). The UH3-GAL4 line, and the
progeny of UH3-GAL4 crossed to w1118 displayed unperturbed
flight ability (FI = 5.88 ± 0.03 and 5.72 ± 0.05, respectively).
“Low dose” expression of all UAS-Act57B actin constructs using
the UH3-GAL4 driver had no effect on flight ability. All
lines displayed flight indices similar to controls (FI = 5.42 –
5.61). Therefore, UH3-GAL4-driven GFP-tagged, wildtype, or
acetyl-mimetic Act57B permitted flight.
Act88F-GAL4 (88F2) Drosophila displayed markedly reduced
flight ability (FI = 1.31 ± 0.12) (Figure 7B). This was
consistent with impaired flight phenotypes observed with
publicly available Act88F-GAL4 lines (w∗; P{Act88F-GAL4.1.3}3
and w∗; P{Act88FGAL4.1.3}81B, P{Act88F:GFP}2/ SM6b) (not
shown). When crossed to w1118 control flies however, female
progeny harboring a single Act88F-GAL4 (88F2) gene exhibited
wildtype-like flight performance (FI = 5.52 ± 0.07). In contrast,
no progeny from the two publicly available Act88F-GAL4 lines,
when crossed to w1118 control flies, regained flight ability (not
shown). Therefore, we exclusively tested and compared flight
performance of the female offspring of Act88F-GAL4 (88F2)
Drosophila crossed to each UAS-Act57B actin transgenic line.
“High dose” Act88F-GAL4> UAS-Act57BGFP.WT expression
eradicated flight (FI = 0.04 ± 0.02) (Figure 7B). Notably,
Act88F-GAL4> UAS-Act57BWT flies demonstrated wildtype-
like flight ability (FI = 5.25 ± 0.09). As with Mef2-
GAL4, expression of UAS-Act57BK326Q via Act88F-GAL4 slightly
depressed flight ability, which closely approached statistical
significance. However, Act88F-GAL4-mediated expression of
UAS-Act57BK328Q andUAS-Act57BK326Q/K328Q caused a complete
loss of flight (FI = 0.04± 0.01 and 0.03± 0.01, respectively).
The Act88F-GAL4> UAS-Act57BK328Q and
UAS-Act57BK326Q/K328Q Flightless Phenotype is
Associated with Hypercontracted IFM
Fluorescent microscopy was employed to inspect the IFM
histopathology in the acetyl-mimetic relative to control flies
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FIGURE 6 | Excessive expression levels of GFP-tagged or
acetyl-mimetic actin disrupt muscle function and structure. (A) Flight
indices of control and of MHC-GAL4> or Mef2-GAL4> UAS-Act57BGFP.WT ,
UAS-Act57BWT , UAS-Act57BK326Q, UAS-Act57BK328Q, or
UAS-Act57BK326Q/K328Q transgenic Drosophila. MHC-GAL4
“low-dose”-driven UAS-Act57B constructs did not affect flight ability in any
transgenic line. “High-dose” expression of UAS-Act57BGFP.WT by
Mef2-GAL4 abolished flight whereas UAS-Act57BWT transgene expression
had no effect on flight performance. Mef2-GAL4-driven expression of
UAS-Act57BK326Q caused a slight but significant reduction in flight ability
(*P < 0.05 compared to controls), while expression of UAS-Act57BK328Q or
UAS-Act57BK326Q/K328Q completely eliminated flight (***P < 0.001
compared to controls). (B) Effects of pseudo-acetylation on climbing ability.
Pseudo-acetylated K326Q actin showed the least and K326Q/K328Q actin
the most damaging effects, which illustrates the PTM can also influence
performance of non-fibrillar muscle (*P < 0.05, ***P < 0.001 compared to
controls; #P < 0.01 compared to Mef2-GAL4> UAS-Act57BK328Q ) (C)
Polarized light micrographs of IFM from Mef2-GAL4> UAS-Act57BWT ,
UAS-Act57BK326Q, UAS-Act57BK328Q, or UAS-Act57BK326Q/K328Q flies.
Mef2-GAL4> UAS-Act57BK326Q IFM appeared indistinguishable from
Mef2-GAL4> UAS-Act57BWT control. Mef2-GAL4-mediated expression of
UAS-Act57BK328Q and UAS-Act57BK326Q/K328Q, however, resulted in a
phenotype consistent with severe hypercontraction. Minor traces of
birefringent material, assumed to be IFM remnants (red arrowheads), were
occasionally observed. A single copy of Mhc10, the IFM-specific myosin null
allele, had no influence on gross muscle morphology in Mef2-GAL4>
UAS-Act57BWT ; Mhc10/+ thoraces. Mef2-GAL4> UAS-Act57BK328Q;
Mhc10/+ Drosophila displayed increased abundance of birefringent thoracic
musculature (red arrowhead) relative to Mef2-GAL4> UAS-Act57BK328Q
flies. The blue arrowhead indicates the tergal depressor of trochanter (jump)
muscle. These findings are consistent with previous studies that
demonstrated reduced MHC partially suppresses fiber destruction and they
suggest that IFM expressing Mef2-GAL4-driven UAS-Act57BK328Q requires
relatively little myosin to hypercontract.
(Figure 7C). Two-day-old Act88F-GAL4> UAS-Act57BK326Q
Drosophila did not show obvious differences in fiber morphology
compared to Act88F-GAL4> UAS-Act57BWT . Similarly-aged
Act88F-GAL4> UAS-Act57BK328Q and UAS-Act57BK326Q/K328Q
Drosophila, in contrast, showed prominently hypercontracted
IFM fibers, characterized by separation and accumulation of fiber
material at one or both attachment sites as previously observed
in other Drosophila muscle mutants (Fyrberg et al., 1990;
Nongthomba et al., 2003). IFMs in very young UAS-Act57BK328Q
expressing adults (< four hour old) had a substantially less severe
phenotype (Figure 7C). Most fibers could be distinctly visualized
with minimal thinning and separation. The results indicated that
the hypercontracted phenotype associated with Act57BK328Q, and
potentially with Act57BK326Q/K328Q acetyl-mimetic actin, was
progressive and deteriorates with age and/or use.
Discussion
Post-translational modifications represent a means to reversibly
or irreversibly alter the physical and chemical nature of
proteins. PTMs thereby modulate the molecules’ properties
and dramatically increase the complexity of biological systems.
For example, even a single protein can exist as a diverse
mixture of many modified forms (Agnetti et al., 2011). Specific
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FIGURE 7 | Disproportionately high expression of UAS-Act57BK328Q
via the Act88F-GAL4 IFM-specific driver induces hypercontraction.
(A) Quantitative western blot analysis of Act57BGFP.WT abundance driven by
UH3-GAL4 vs. Act88F-GAL4. GFP intensities were normalized to that of
GAPDH and averaged for eight IFM samples with four technical replicates
each. Act88F-GAL4 drove significantly higher amounts of transgenic actin
relative to UH3-GAL4 (**P < 0.01). (B) Flight indices of UH3-GAL4> and
Act88F-GAL4> UAS-Act57BGFP.WT , UAS-Act57BWT , UAS-Act57BK326Q,
UAS-Act57BK328Q, and UAS-Act57BK326Q/K328Q transgenic Drosophila.
UH3-GAL4, and “low dose” expression of all UAS-Act57B actin constructs
by the driver, had no effect on flight. Act88F-GAL4 Drosophila exhibited
significantly reduced flight performance relative to female progeny of
Act88F-GAL4 x w1118 (#P < 0.001). The latter demonstrated wild-type-like
flight ability. “High-dose” expression of UAS-Act57BGFP.WT by Act88F-GAL4
eliminated flight whereas UAS-Act57BWT transgene expression had no
effect on flight performance. “High dose” expression of UAS-Act57BK326Q
reduced flight ability, an effect which approached statistical significance.
Act88F-GAL4> UAS-Act57BK328Q and UAS-Act57BK326Q/K328Q
Drosophila were flightless (***P < 0.001). (C) Fluorescent images of dorsal
longitudinal IFMs from two-day-old Act88F-GAL4> UAS-Act57BWT ,
UAS-Act57BK326Q, UAS-Act57BK328Q, and UAS-Act57BK326Q/K328Q flies.
Act88F-GAL4> UAS-Act57BK326Q IFMs were indistinguishable from
Act88F-GAL4> UAS-Act57BWT control IFMs. Act88F-GAL4>
UAS-Act57BK328Q and UAS-Act57BK326Q/K328Q Drosophila, however,
displayed hypercontracted IFM with separated and bunched fibers (red
arrowheads) at attachment sites. IFMs from young (four hour old)
UAS-Act57BK328Q-expressing flies had a considerably less severe
phenotype with minimal thinning and separation of the fibers.
measurements of a number of PTMs have revealed that several
residues of a particular protein can be modified. Moreover,
different PTMs may compete with each other for access to a
single residue on the same protein. Based on an annotated human
database, 62% of cardiac proteins have at least one PTM with
phosphorylation dominating, whereas 25% have multiple types
of modifications (van Eyk, 2011).
The cardiac thin filament is subject to a host of PTMs that
markedly influence the properties of the constituent subunits and
can directly affect contractile regulation and muscle performance
(Metzger andWestfall, 2004; Sumandea et al., 2004; Agnetti et al.,
2011; Solaro and Kobayashi, 2011; van Eyk, 2011). However,
the modified status of these proteins is infrequently accounted
for in in silico and in vitro experiments. As investigation and
discovery of myocardial protein PTMs intensify, determining the
in vivo consequences of modifying amino acid residues that lie
at highly conserved and at potentially critical locations becomes
increasingly important. Establishing model systems that limit
genetic diversity and benefit from robust and relatively efficient
transgenic tools for organism development and high throughput
physiological assessment is imperative.
Here we provide novel data pertaining to recently identified
PTMs using Drosophila that express pseudo-acetylated K326Q,
K328Q, or K326Q/K328Q cardiac actin in a muscle-restricted
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manner. Transgenic actin expression was confirmed via thoracic
and IFM-specific cDNA analysis and by GFP-based reporter
imaging. As previously found with similar GFP-tagged constructs
(Röper et al., 2005; Perkins and Tanentzapf, 2014), we observed
restricted and repetitive incorporation of transgenic GFP-actin
along IFM myofibrils, which, as evaluated by phalloidin labeling,
were indistinguishable from wild-type myofibrils (not shown).
Röper et al. reported that the IFM was the only muscle in which
function was affected by overexpression of GFP-labeled actin
(Röper et al., 2005). Muscle-restricted expression of muscle or
cytoplasmic GFP-actins using the UAS-GAL4 system was shown
to yield flightless adults that were otherwise healthy and fertile.
Consistent with earlier studies, it was postulated that impaired
IFM function, and in some cases the disrupted flight muscle
structure, resulted from an imbalance in the relative amounts of
actin and myosin (Beall et al., 1989; Bernstein et al., 1993; Röper
et al., 2005; Vigoreaux, 2006). Furthermore, Fyrberg et al. (1998)
showed that Drosophila exclusively expressing chimeric actin,
consisting of part of Act57B fused with the remaining portion
of Act88F in their IFM, exhibited decreased flight ability. Thus,
in addition to actin and myosin stoichiometric discrepancies
that potentially influence performance, these findings suggest
functional non-equivalence of actin isoforms and that the IFM
is also exquisitely sensitive to actin sequence variation. However,
we observed that “low dose” expression of GFP-actin using
the MHC- or UH3-GAL4 driver did not impair flight and
that expression of non-GFP-tagged wildtype Act57B actin via
MHC-, Mef2-, UH3-, or Act88F-GAL4 muscle-specific drivers
had no influence on Drosophila flight ability. Therefore, despite
differences in 9 amino acid residues between Act88F and Act57B
actin isoforms (Figure 2), incorporation of non-mutant cardiac
actin into IFMmyofibrils appeared to support flight at expression
levels dictated by each GAL4 driver. These results imply that
the GFP moiety of excessively overexpressed GFP-fused actins
directly impairs flight. This may be due, in part, to perturbed Tm
movement or myosin crossbridge binding in the IFM consistent
with the N-terminal fluorescent protein tag located proximal
to Tm and myosin binding sites on actin. Importantly, our
findings illustrate that GAL4-mediated transgene expression can
be employed to investigate the effects of non-GFP tagged cardiac
actinmodifications on the readily measurable index of flight.
Compared to UAS-Act57BWT cardiac actin expression,
expression of mutant acetyl-mimetic cardiac actin had a
dose-dependent effect on flight ability. Moreover, robust
expression of UAS-Act57BK328Q and UAS-Act57BK326Q/K328Q
via Mef2- or Act88F-GAL4 induced a greater reduction in
flight performance relative to UAS-Act57BK326Q. Mef2- or
Act88F-GAL4-driven Act57BK326Q also had no resolvable effect
on gross IFM morphology. It is conceivable that, rather
than a direct effect of K→Q substitution on contraction,
the milder phenotype associated with Act57BK326Q might be
attributable to reduced actin monomer incorporation, owing
to a decrease in protein stability or increase in protease
accessibility caused by the mutation. Though difficult to rule
out confounding effects on protein stability, the preponderance
of buttressing evidence suggests that Act57BK326Q exerts
direct yet modest effects on contractile function. Namely,
in addition to slightly depressing flight ability, Mef2-GAL4>
UAS-Act57BK326Q flies exhibited significantly reduced climbing
ability. Moreover, Mef2-GAL4> UAS-Act57BK326Q/K328Q flies
displayed impaired climbing relative to Mef2-GAL4> UAS-
Act57BK328Q flies. The latter results also highlight an influence
of pseudo-acetylated actin on non-fibrillar adult somatic
muscles.
The absence of flight in Act57BK328Q and Act57BK326Q/K328Q-
expressing flies was associated with a “wings up” phenotype and
a loss of IFM fibers. Mutations in Drosophila muscle proteins
frequently produce a phenotype referred to as hypercontraction
(Fyrberg et al., 1990; Beall and Fyrberg, 1991; Kronert et al., 1995;
An and Mogami, 1996; Reedy et al., 2000; Nongthomba et al.,
2003). This degenerative syndrome is characterized by muscles
that begin to develop normally, and then auto-destruct in an
apparently myosin-dependent manner. The IFM of the troponin
I and T mutants, hdp2 and up101, respectively, initially develop
normally and begin to show signs of degeneration 78 h after
puparium formation, concomitant with initial muscle twitching
in the developing imago (Naimi et al., 2001; Nongthomba et al.,
2003). By the second day of adult life very few sarcomeres remain
(Beall and Fyrberg, 1991). The onset of hypercontraction suggests
that it is a result of muscle activation, and is not due to abnormal
development (Nongthomba et al., 2003).
Both hdp2 and up101 thin filaments exhibit aberrantly
positioned Tm in the absence of Ca2+, which results in
exposed myosin binding sites at rest (Cammarato et al., 2004;
Viswanathan et al., 2014). Consequently, IFM hypercontraction
is believed to result from excessive actomyosin interaction
and unregulated force production. Models of the F-actin-Tm
interface reveal K326 and K328 of actin participate in vital
intermolecular electrostatic associations with Tm to establish an
energetically favorable conformation (Brown and Cohen, 2005;
Li et al., 2011; Barua et al., 2012, 2013; Lehman et al., 2013).
Here, Tm is located in an azimuthal location that occludes
myosin binding sites on F-actin. Moreover, a recent model of
the F-actin-Tm-myosin interface reveals K328 on actin can also
directly interact with strongly bound myosin heads (Behrmann
et al., 2012). Our data suggest that sufficiently high acetylation
of these actin residues can weaken actin-Tm interaction and
disrupt the ability of Tm to properly block crossbridge formation
and force transmission to the thin filament. Therefore, as with
the aforementioned troponinmutations, the acetyl-mimetic actin
may similarly trigger hypercontraction. Interestingly, the effect of
modifying K328 triggered more severe defects relative to K326,
which indicates K328may bemost essential for proper relaxation,
in vivo. Moreover, since K328Q actin may also impair strong S1
binding, which is predicted to oppose hypercontraction, our data
imply the effects of potentially weakening S1-actin association
are less harmful than those that influence Tm positioning, as the
muscles still hypercontract.
The importance of these actin residues in thin filament
regulation, and the effects associated with potential loss of charge,
are further underscored by naturally occurring mutations. For
example, the K326N nemaline myopathy actin mutation, which
differs from the K326Q acetyl-mimetic isoform investigated
here by a single methylene bridge, was reported in patients
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with stiff muscles and spontaneous contractures, suggesting a
hypercontractile phenotype (Jain et al., 2012). Computation of
the energy landscape for this mutant revealed reduced actin-Tm
interaction energy, which would facilitate a shift of Tm away
from myosin binding sites, and would explain the increased
Ca2+-sensitivity and hypercontractility of affected muscles (Jain
et al., 2012; Orzechowski et al., 2014). Considering the severity
of the effects accompanied by high expression of the K328Q
mutation observed in the current study, similar charge loss at
K328 may not be well-tolerated in higher organisms.
Based on F-actin-Tm, F-actin-Tm-myosin models, and our
physiological data, we believe that acetylation of K326 and K328
of actin alters electrostatic associations with Tm and/or myosin,
destabilizes Tm’s inhibitory position, and thereby enhances
actomyosin associations and promotes IFM hypercontraction
and muscle destruction. However, our approach does not
preclude possible alternative contributors to muscle pathology.
For example, the amino acid substitutions may compromise
the folding efficiency, thermal stability, and/or polymerization
properties of actin filaments as recently observed for particular
cardiomyopathy-causing lesions (Mundia et al., 2012; Müller
et al., 2012). Thus, increased F-actin and thin filament
lability may promote myofilament and sarcomeric degeneration.
Additionally, though our data suggest that sufficiently high doses
of actyl-mimetic actins are required to elicit dysfunction, we
cannot rule out a potential contribution from early transgene
activation via the Mef2-GAL4 driver, relative to the others,
that disrupts muscle development (Markstein et al., 2008).
Thus, the most severe IFM phenotype, which was observed
in Mef2-GAL4> UAS-Act57BK328Q and UAS-Act57BK326Q/K328Q
Drosophila, may be due to both abundant quantities and
premature activation times of transgene expression. If K326
and K328 of actin are required for proper thin filament
regulation, excessive myosin binding and force production
during early muscle development may alter the core building
blocks required for proper IFM formation and irreversibly
disrupt myofibrillogenesis. This is not unreasonable since during
development actomyosin associations appear compulsory for
well-ordered and properly functioning IFM (Cripps et al., 1999).
However, we detected a greater abundance of birefringent
IFM material in Mef2-GAL4> UAS-Act57BK328Q thoraces when
myosin was reduced. Moreover, relative to Mef2-GAL4> UAS-
Act57BK328Q, delayed expression of UAS-Act57BK328Q actin via
Act88F-GAL4 led to a less severe phenotype characterized by
post-eclosion progressive separation and accumulation of fiber
material to IFM attachment sites. Thus, we interpret these
results as consistent with the previously described myosin-
dependent, degenerative hypercontraction syndrome and not
with a complete lack of IFM development (Nongthomba et al.,
2003).
Here we provide in vivo confirmation of a requirement
for positively charged lysine residues at amino acid positions
326 and 328 on actin for proper thin filament function. We
demonstrate how PTMs that sufficiently mask these vital charges
can have dramatic consequences on muscle performance and
structure. While LC-MS/MS analysis of myofilament enriched
subfractions of guinea pig hearts revealed lysines 326 and 328
were acetylated, stoichiometry was not assessed (Foster et al.,
2013). Our current data suggest Mef2-GAL4-driven transgenic
actin comprises approximately 10–20% of total actin (not
shown), while MHC-GAL4 drives significantly less. Therefore,
minor changes in a potentially small acetylated myofilamentous
actin pool may have substantial repercussions on muscle
properties. Masking the charges at K326 and K328 apparently
increases muscle function by potentially lowering actin-Tm
interaction energy, altering Tm positioning, and perpetually
promoting myosin crossbridge formation and contraction.
Disproportionately excessive amounts of K326 and K328
acetylation and hypercontractile activity in vertebrate hearts may
be deleterious as observed here. Nonetheless, small populations
of acetylated K326 and K328 could have beneficial effects
under normal conditions that act to augment the contractile
properties of muscle. In disease however, particularly aﬄictions
characterized by nutrient excess such as diabetes, elevated acetyl-
CoA levels may lead to increased acetylation of these critical actin
residues and possibly exacerbate pathology.
Investigating the effects of myofilament protein modifications
on distinct Drosophila muscles will facilitate our effort to
understand the molecular basis of contractile regulation and,
importantly, of potentially tempering myopathic responses.
Biochemical, biophysical, and structural studies frequently
neglect to account for PTMs of myofilamentous proteins,
which can greatly modulate contractile behavior. Thus, to
truly comprehend muscle performance in health and disease,
consideration needs to be given to these dynamic protein
modifications.Drosophila facilitates genetic manipulation of thin
filament components and evaluation of the consequences of
perturbation. Moreover, since abundant quantities of native IFM
thin filaments and actin can be isolated for in vitro studies (Bing
et al., 1998; Razzaq et al., 1999; Cammarato et al., 2004; Vikhorev
et al., 2010), the models permit hierarchical investigation
of the effects of such PTMs on contractile machinery from
the molecular through the tissue level. Overall, our findings
emphasize the utility of Drosophila as a model system that allows
for control of genetic modifiers and environmental factors and
that enables efficient targeted design and assessment of molecular
and tissue-specific responses to protein modifications in the
physiological context of muscle.
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